Feed aggregator

Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy

Biospace news - 13 hours 28 min ago
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy 3/28/2024

Boundless Bio Launches $100M IPO to Advance Cancer Therapy Candidates

Biospace news - 13 hours 28 min ago
Boundless Bio Launches $100M IPO to Advance Cancer Therapy Candidates 3/28/2024

How to Set and Maintain Boundaries at Work

Biospace news - 13 hours 28 min ago
How to Set and Maintain Boundaries at Work 3/28/2024

Shared digital NHS prescribing record could avoid nearly 1 million annual drug errors

World Pharma News - Wed, 03/27/2024 - 11:00
Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed, and saving up to 22 lives every year, suggests a modelling study, published online in BMJ Quality & Safety.

The figures, which are based on the assumption that such a system could reduce medication errors by at least 10%, and by as much as 50%, could also save £millions for the NHS, say the researchers.

Novocure Gets Phase III Win in Patients with Brain Metastases from Lung Cancer

Biospace news - Wed, 03/27/2024 - 02:00
Novocure Gets Phase III Win in Patients with Brain Metastases from Lung Cancer 3/27/2024

Opinion: AbbVie-Landos Deal Signals Continued Momentum for Next-Gen I&I Drugs

Biospace news - Wed, 03/27/2024 - 02:00
Opinion: AbbVie-Landos Deal Signals Continued Momentum for Next-Gen I&I Drugs 3/27/2024

Nanoscope Claims Phase II Win for Gene Therapy After Changing Primary Endpoint

Biospace news - Wed, 03/27/2024 - 02:00
Nanoscope Claims Phase II Win for Gene Therapy After Changing Primary Endpoint 3/27/2024

Moderna Secures Up to $750M in Funding from Blackstone to Advance Flu Program

Biospace news - Wed, 03/27/2024 - 02:00
Moderna Secures Up to $750M in Funding from Blackstone to Advance Flu Program 3/27/2024

Pfizer Terminates Phase III Sickle Cell Study Due to Slow Patient Recruitment

Biospace news - Wed, 03/27/2024 - 02:00
Pfizer Terminates Phase III Sickle Cell Study Due to Slow Patient Recruitment 3/27/2024

Avenzo Closes $150M Oversubscribed Series A-1 to Advance Cancer Therapies

Biospace news - Wed, 03/27/2024 - 02:00
Avenzo Closes $150M Oversubscribed Series A-1 to Advance Cancer Therapies 3/27/2024

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData

Biospace news - Wed, 03/27/2024 - 02:00
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData 3/27/2024

Bayer’s Sweeping Executive Cuts, Wegovy’s Expanding Reach

Biospace news - Wed, 03/27/2024 - 02:00
Bayer’s Sweeping Executive Cuts, Wegovy’s Expanding Reach 3/27/2024

Global Healthcare Celebrates Tech Successes & Grapples with Cybersecurity at HIMSS 2024

Biospace news - Wed, 03/27/2024 - 02:00
Global Healthcare Celebrates Tech Successes & Grapples with Cybersecurity at HIMSS 2024 3/27/2024

Analysts Predict Slower Rollout but Ultimate Victory for Casgevy in Race with Lyfgenia

Biospace news - Wed, 03/27/2024 - 02:00
Analysts Predict Slower Rollout but Ultimate Victory for Casgevy in Race with Lyfgenia 3/27/2024

C-Suite Shuffle: A2 Bio, Bayer, BioNTech and More

Biospace news - Wed, 03/27/2024 - 02:00
C-Suite Shuffle: A2 Bio, Bayer, BioNTech and More 3/27/2024

Opinion: Biopharma Should Prioritize Research on the Economics of Therapies

Biospace news - Wed, 03/27/2024 - 02:00
Opinion: Biopharma Should Prioritize Research on the Economics of Therapies 3/27/2024

In an Evolving Market, HR Leaders Balance Business Needs with Employee Engagement

Biospace news - Wed, 03/27/2024 - 02:00
In an Evolving Market, HR Leaders Balance Business Needs with Employee Engagement 3/27/2024

Biopharma Layoff Tracker 2024: Bayer, BMS, Theratechnologies and More Cut Staff

Biospace news - Wed, 03/27/2024 - 02:00
Biopharma Layoff Tracker 2024: Bayer, BMS, Theratechnologies and More Cut Staff 3/27/2024

FDA Approves New Treatments for Two Rare Diseases

Biospace news - Wed, 03/27/2024 - 02:00
FDA Approves New Treatments for Two Rare Diseases 3/27/2024

Global study could change how children with multiple sclerosis are treated

World Pharma News - Tue, 03/26/2024 - 11:00
A ground-breaking study - the largest of its kind globally - has found children with multiple sclerosis (MS) have better outcomes if treated early and with the same high-efficacy therapies as adults.

There are a limited number of therapies approved for children with MS, with only one considered to be of high-efficacy - meaning highly effective.